Director II, Portfolio Insights

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas including immunology, oncology, and neuroscience, as well as products and services in our Allergan Aesthetics portfolio.

The Portfolio Insights team enables Abb Vie to make data-driven portfolio decisions across its multi-billion-dollar annual R&D investment.

The Director II, Portfolio Insights will lead a team of approximately three colleagues responsible for cross‑TA portfolio insights and prioritization, including execution of the quarterly portfolio prioritization process. This role reports directly to the Head of Portfolio Insights.

This role is accountable for advancing cross‑TA prioritization by ensuring consistency in approach across therapeutic areas, driving alignment to portfolio prioritization objectives, and developing clear, decision-oriented visualizations for senior governance discussions. The position sets the vision and strategy for portfolio‑level insights on R&D investment choices, partners closely with senior leaders and functional stakeholders across the organization, aligns diverse inputs, guides the development of productivity analyses, leads scenario‑based evaluations, and delivers high‑quality outputs that support enterprise decision‑making.

• Lead cross‑TA portfolio analyses focused on the organization’s highest‑priority strategic questions and serve as a central point of leadership for these efforts
• Serve as a trusted partner to Finance in delivering key outputs, including the Plan Book and Financial LRP process
• Build strong relationships across TASC, PPM, Commercial Forecasting, Finance, and Strategic Resourcing to understand stakeholder needs and develop insightful cross‑TA analyses and practices grounded in objective decision support
• Coach and enable the team to engage effectively with functional stakeholders, strengthen linkages across portfolio inputs, and challenge assumptions constructively
• Ensure an appropriate balance between consistency across therapeutic areas and the flexibility to reflect TA‑specific nuance, while maintaining transparency across teams
• Guide the team in developing portfolio‑level outputs with clear scenarios and trade‑offs to support senior leadership decisions on portfolio investments
• Anticipate senior leadership questions, proactively frame potential portfolio scenarios, and lead scenario‑based analyses to inform key governance discussions
• Present key findings and strategic insights to senior leadership and across TASC, as needed
• Drive continuous improvement in cross‑TA insight generation and prioritization processes
• Lead ad hoc, short‑term analyses and strategic projects in response to leadership priorities

• Bachelor’s degree in a scientific or business field required; advanced degree (e.g., Pharm
  
  D, PhD, MD, MBA) highly preferred
• Prior experience in management consulting, with a track record in R&D strategy / portfolio prioritization projects, strongly preferred
• 10+ years of experience with a multifaceted, broad‑based understanding of pharmaceutical R&D business processes, investment stage gating, and commercial processes; fewer years may be considered for candidates with advanced degrees (e.g., MBA, PhD)
• Preferred years of experience: 10+ with a Bachelor’s, 8+ with a Master’s, or 6+ with a Doctorate
• Proven people management experience, with a strong track record of coaching and developing talent
• Excellent analytical and problem‑solving skills, with demonstrated ability to manage multiple priorities in a fast‑paced environment
• Proven track record of leading complex cross‑TA initiatives and delivering enterprise‑level impact
• Strong communication skills and executive presence, with the ability to shape consensus and promote enterprise thinking
• Strong organizational and project management skills, with the ability to lead a team and deliver multiple sophisticated cross‑TA analyses across several assets

• Portfolio governance: PPM (Program and…